Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

MGXMetagenomi Therapeutics, Inc.

Nasdaq · CIK 0001785279
Filer category<br>Emerging growth company
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts229

Identity from submissions API

NameMetagenomi Therapeutics, Inc.
CIK0001785279
TickersMGX
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN813909017
LEI—
Fiscal year end1231
State of incorporation—
Phone(510) 871-4880
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Metagenomi, Inc. (2023-08-31T04:00:00.000Z → 2026-01-12T05:00:00.000Z)
  • Metagenomi Technologies, LLC (2019-08-16T04:00:00.000Z → 2024-01-18T05:00:00.000Z)
Business address
5959 HORTON STREET
7TH FLOOR
EMERYVILLE
CA
94608
CA
Mailing address
5959 HORTON STREET
7TH FLOOR
EMERYVILLE
CA
94608
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

157 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 8-K 8-K 7.01,9.01 0001193125-26-463400 001-41949 261560170 34 10653791 1 1
2026-11-10 10-Q 10-Q 0001193125-26-455441 001-41949 261540377 34 10171148 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-455436 001-41949 261540342 34 1221736 1 1
2026-09-22 8-K 8-K 7.01,9.01 0001193125-26-397037 001-41949 261395076 34 10383699 1 1
2026-09-11 4 4 0001193125-26-389550 6445
2026-09-10 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-387853 005-94514 261371067 34 6919
2026-09-10 4 4 0001193125-26-387816 5250
2026-09-10 4 4 0001193125-26-387798 7502
2026-09-10 4 4 0001193125-26-387786 5173
2026-08-10 10-Q 10-Q 0001193125-26-342400 001-41949 261258547 34 12799822 1 1
2026-08-10 8-K 8-K 2.02,9.01 0001193125-26-342388 001-41949 261258496 34 364431 1 1
2026-06-11 4 4 0001193125-26-267272 5692
2026-06-11 4 4 0001193125-26-267255 5693
2026-06-11 4 4 0001193125-26-267189 5652
2026-06-11 4 4 0001193125-26-267170 5691
2026-06-10 4 4 0001193125-26-265335 5172
2026-06-10 4 4 0001193125-26-265332 7696
2026-06-10 4 4 0001193125-26-265326 5444
2026-06-10 8-K 8-K 5.02,5.07 0001193125-26-264392 001-41949 261077399 34 168921 1 1
2026-05-11 10-Q 10-Q 0001193125-26-216774 001-41949 26963296 34 8531154 1 1
2026-05-11 8-K 8-K 2.02,7.01,9.01 0001193125-26-216763 001-41949 26963247 34 11128077 1 1
2026-04-27 ARS ARS 0001193125-26-182345 001-41949 26901846 34 4809199
2026-04-27 DEFA14A DEFA14A 0001193125-26-182339 001-41949 26901834 34 1878886 1 1
2026-04-27 DEF 14A DEF 14A 0001193125-26-182325 001-41949 26901808 34 2639843 1 1
2026-04-03 4 4 0001193125-26-141946 9825
2026-04-03 4 4 0001193125-26-141914 7556
2026-04-03 4 4 0001193125-26-141867 7489
2026-03-09 4 4 0001193125-26-098824 5015
2026-03-09 4 4 0001193125-26-098821 5110
2026-03-09 4 4 0001193125-26-098820 9055
2026-03-05 S-8 S-8 0001193125-26-094014 333-294054 26726421 33 358560 1 1
2026-03-05 10-K 10-K 0001193125-26-093976 001-41949 26726285 34 28079894 1 1
2026-03-05 8-K 8-K 2.02,9.01 0001193125-26-093943 001-41949 26726181 34 694708 1 1
2026-01-12 8-K 8-K 5.03,7.01,9.01 0001193125-26-009928 001-41949 26525063 34 9931955 1 1
2025-12-08 4 4 0001193125-25-310971 4824
2025-12-08 4 4 0001193125-25-310958 4955
2025-12-08 4 4 0001193125-25-310953 4886
2025-12-08 4 4 0001193125-25-310937 4877
2025-12-01 4 4 0001193125-25-304221 4822
2025-12-01 4 4 0001193125-25-304218 6566
2025-12-01 4 4 0001193125-25-304212 10878
2025-12-01 4 4 0001193125-25-304177 6901
2025-11-12 10-Q 10-Q 0001193125-25-276150 001-41949 251469395 34 11327619 1 1
2025-11-12 8-K 8-K 2.02,7.01,9.01 0001193125-25-276135 001-41949 251469384 34 9084877 1 1
2025-10-01 8-K 8-K 1.01,1.02 0001193125-25-226878 001-41949 251365229 34 156599 1 1
2025-09-11 144 xsl144X01/primary_doc.xml 0002007317-25-001071 001-41949 251308809 33 4844
2025-09-02 4 4 0000950170-25-112535 5391
2025-08-15 3 3 0000950170-25-109376 12084
2025-08-12 10-Q 10-Q 0000950170-25-107308 001-41949 251206746 34 10250087 1 1
2025-08-12 8-K 8-K 2.02,7.01,9.01 0000950170-25-107304 001-41949 251206695 34 16008317 1 1
2025-07-09 144 xsl144X01/primary_doc.xml 0001968582-25-000580 001-41949 251114526 33 4957
2025-06-12 4 4 0000950170-25-085499 5422
2025-06-12 4 4 0000950170-25-085488 5394
2025-06-12 4 4 0000950170-25-085483 5380
2025-06-11 8-K 8-K 5.07 0000950170-25-084529 001-41949 251038386 34 163758 1 1
2025-06-09 4 4 0000950170-25-083963 4973
2025-06-09 4 4 0000950170-25-083952 4873
2025-06-09 4 4 0000950170-25-083949 4883
2025-06-09 4 4 0000950170-25-083947 4887
2025-06-09 4 4 0000950170-25-083930 4932
2025-05-14 8-K 8-K 8.01 0000950170-25-070906 001-41949 25942630 34 581646 1 1
2025-05-13 10-Q 10-Q 0000950170-25-070463 001-41949 25940859 34 9483276 1 1
2025-05-13 8-K 8-K 2.02,7.01,9.01 0000950170-25-070448 001-41949 25940764 34 15935047 1 1
2025-04-28 ARS ARS 0000950170-25-059305 001-41949 25880407 34 2619781
2025-04-28 DEFA14A DEFA14A 0000950170-25-059287 001-41949 25880214 34 1260225
2025-04-28 DEF 14A DEF 14A 0000950170-25-059276 001-41949 25880113 34 3595947 1 1
2025-04-03 4 4 0000950170-25-050103 7216
2025-04-03 4 4 0000950170-25-050102 7222
2025-04-03 4 4 0000950170-25-050101 9556
2025-04-03 4 4 0000950170-25-050100 11040
2025-04-03 4 4 0000950170-25-050098 7206
2025-03-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000782 333-285867 25769895 33 1836
2025-03-21 CORRESP filename1.htm 0000950170-25-043167 19104
2025-03-21 UPLOAD filename1.pdf 0000000000-25-003067 333-285867 40150
2025-03-17 8-K 8-K 1.01,9.01 0000950170-25-040453 001-41949 25745442 34 169107 1 1
2025-03-17 S-3 S-3 0000950170-25-040421 333-285867 25745339 33 3303744 1 1
2025-03-17 S-8 S-8 0000950170-25-040290 333-285860 25744668 33 358646 1 1
2025-03-17 8-K 8-K 2.02,7.01,9.01 0000950170-25-040238 001-41949 25744433 34 15767481 1 1
2025-03-17 10-K 10-K 0000950170-25-040217 001-41949 25744299 34 21052218 1 1
2025-03-07 4 4 0000950170-25-035566 5525
2025-03-07 4 4 0000950170-25-035565 5436
2025-02-05 4 4 0000950170-25-014528 5359
2025-01-27 3 3 0000950170-25-009328 12559
2025-01-16 8-K 8-K 5.02,7.01,9.01 0000950170-25-006028 001-41949 25534409 34 7770511 1 1
2024-12-10 8-K 8-K 8.01,9.01 0000950170-24-134733 001-41949 241536896 34 341748 1 1
2024-12-06 4 4 0000950170-24-134124 4890
2024-11-13 8-K 8-K 2.02,9.01 0000950170-24-126317 001-41949 241454142 34 472903 1 1
2024-11-13 10-Q 10-Q 0000950170-24-126273 001-41949 241453864 34 10059955 1 1
2024-11-06 SC 13G SC 13G 0001104659-24-114820 005-94514 241431614 34 84598
2024-09-06 4 4 0000950170-24-104439 5215
2024-09-03 8-K 8-K 8.01,9.01 0000950170-24-102805 001-41949 241274119 34 344157 1 1
2024-08-14 8-K 8-K 2.02,9.01 0000950170-24-096673 001-41949 241204311 34 477625 1 1
2024-08-14 10-Q 10-Q 0000950170-24-096665 001-41949 241204250 34 9739162 1 1
2024-05-14 8-K 8-K 2.02,7.01,9.01 0000950170-24-059532 001-41949 24944354 34 13086179 1 1
2024-05-14 10-Q 10-Q 0000950170-24-059504 001-41949 24944178 34 8594947 1 1
2024-05-10 SC 13G SC 13G 0001104659-24-060040 005-94514 24936456 34 157298
2024-05-01 8-K 8-K 1.02,2.02,7.01,9.01 0000950170-24-051238 001-41949 24902847 34 7475465 1 1
2024-04-03 4 4 0000950170-24-041571 9567
2024-04-03 4 4 0000950170-24-041569 5396
2024-04-03 4 4 0000950170-24-041551 7256
2024-04-03 4 4 0000950170-24-041545 7315
2024-04-03 4 4 0000950170-24-041537 7240
2024-04-03 4 4 0000950170-24-041527 7220
2024-04-03 4 4 0000950170-24-041521 5396
2024-04-03 4 4 0000950170-24-041515 7308
2024-04-03 4 4 0000950170-24-041483 7306
2024-04-03 4 4 0000950170-24-041471 5368
2024-04-03 4 4 0000950170-24-041449 7234
2024-03-27 8-K 8-K 2.02,9.01 0000950170-24-036847 001-41949 24786078 34 430645 1 1
2024-03-27 10-K 10-K 0000950170-24-036838 001-41949 24785956 34 27565050
2024-02-15 4 FORM 4 SUBMISSION 0001209191-24-003423 12839
2024-02-15 4 PRIMARY DOCUMENT 0001578563-24-000080 24346
2024-02-15 3 PRIMARY DOCUMENT 0001578563-24-000079 14009
2024-02-14 4 4 0000950170-24-015269 20836
2024-02-13 8-K 8-K 5.03,9.01 0001193125-24-033697 001-41949 24625809 34 167528
2024-02-12 424B4 424B4 0001193125-24-031007 333-276413 24617333 33 12479950
2024-02-09 S-8 S-8 0001193125-24-030109 333-276983 24615556 33 89266
2024-02-08 SEC STAFF LETTER filename1.pdf 9999999997-24-000274 63916
2024-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-02-08 16:00:00 9999999995-24-000355 333-276413 24610965 33 1843
2024-02-08 3 FORM 3 SUBMISSION 0001209191-24-003012 5661
2024-02-08 3 3 0000950170-24-012972 15251
2024-02-08 3 3 0000950170-24-012971 16756
2024-02-08 3 3 0000950170-24-012970 15524
2024-02-08 3 3 0000950170-24-012968 23988
2024-02-08 3 3 0000950170-24-012967 16384
2024-02-08 3 3 0000950170-24-012963 15090
2024-02-08 3 3 0000950170-24-012959 15451
2024-02-08 3 3 0000950170-24-012956 16235
2024-02-08 3 3 0000950170-24-012955 15478
2024-02-08 3 3 0000950170-24-012949 16647
2024-02-08 3 3 0000950170-24-012947 17908
2024-02-08 CERT 8A_cert_MGX.pdf 0001354457-24-000050 001-41949 24608446 34 179213
2024-02-07 CORRESP filename1.htm 0001193125-24-026684 18778
2024-02-07 S-1/A S-1/A 0001193125-24-026662 333-276413 24604343 33 12565966
2024-02-06 UPLOAD filename1.pdf 0000000000-24-001452 377-06800 43996
2024-02-06 CORRESP filename1.htm 0001193125-24-025158 15552
2024-02-06 CORRESP filename1.htm 0001193125-24-025156 7168
2024-02-05 8-A12B 8-A12B 0001193125-24-024168 001-41949 24596714 34 14686
2024-02-05 CORRESP filename1.htm 0001193125-24-024042 14686
2024-02-05 S-1/A S-1/A 0001193125-24-023377 333-276413 24593854 33 14682307
2024-01-18 CORRESP filename1.htm 0001193125-24-010328 18316
2024-01-16 CORRESP filename1.htm 0001193125-24-008144 103848
2024-01-08 S-1/A S-1/A 0001193125-24-003810 333-276413 24518191 33 12272350
2024-01-05 CORRESP filename1.htm 0001193125-24-003490 18607
2024-01-05 S-1 S-1 0001193125-24-003477 333-276413 24517522 33 17924086
2023-12-20 UPLOAD filename1.pdf 0000000000-23-013894 377-06800 42867
2023-12-11 DRS/A filename1.htm 0000950123-23-011148 377-06800 231476800 33 15437742
2023-09-18 SEC STAFF LETTER filename1.pdf 9999999997-23-004206 64994
2023-09-07 DRSLTR filename1.htm 0000950123-23-008456 44329
2023-09-07 DRS/A filename1.htm 0000950123-23-008455 377-06800 231242067 33 13124254
2023-08-31 UPLOAD filename1.pdf 0000000000-23-009615 377-06800 57771
2023-08-03 DRS filename1.htm 0000950123-23-006615 377-06800 231141140 33 10171818
2023-01-11 D xslFormDX01/primary_doc.xml 06b 0001785279-23-000001 021-470286 23522295 33 9752
2022-02-07 D xslFormDX01/primary_doc.xml 06b 0001785279-22-000001 021-432586 22596635 33 9590
2021-03-29 D xslFormDX01/primary_doc.xml 06b 0001785279-21-000001 021-393845 21780800 33 9177
2020-11-25 D xslFormDX01/primary_doc.xml 06b 0001785279-20-000001 021-381574 201351316 33 8431
2019-08-16 D xslFormDX01/primary_doc.xml 06b 0001785279-19-000002 021-346741 191032333 33 7484

Latest XBRL company facts

One latest value per concept from companyfacts (229 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 37.81M 2026-11-06 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
dei EntityPublicFloat Entity Public Float USD 50.93M 2025-06-30 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 8.42M 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 773,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 687,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 16.18M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 998,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 15.96M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -159,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 475.88M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 1.78M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 6.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 181,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-276150
us-gaap Assets Assets USD 157.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AssetsCurrent Assets, Current USD 110.86M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 159,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 101.83M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedGain Debt Securities, Available-for-sale, Unrealized Gain USD 401,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107308
us-gaap AvailableForSaleDebtSecuritiesGrossUnrealizedLoss Debt Securities, Available-for-sale, Unrealized Loss USD 30,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-12 0000950170-25-107308
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 6.04M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 6.04M 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value USD 65.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost USD 65.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One USD 65.73M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 65.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 101.67M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 65.57M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 124,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-216774
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 36.11M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 101.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 40.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -6.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 37.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 37.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap CommonStockValue Common Stock, Value, Issued USD 4,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -72.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 9.01M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 2.30M 2026-04-30 2026 Q2 10-Q 2026-08-10 0001193125-26-342400
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 350.76M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 9.46M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -58,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD -58,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease DebtSecuritiesAvailableForSaleExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DebtSecuritiesAvailableForSalePurchasedWithCreditDeteriorationAmountAtPurchasePrice Debt Securities, Available-for-sale, Purchased with Credit Deterioration, Amount at Purchase Price USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 12.18M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 300,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-11 0001193125-26-216774
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 3.44M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 104.56M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 51.73M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 175.30M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 45.60M 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 213.50M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 8.15M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxAssetsTaxDeferredExpense Deferred Tax Assets, Tax Deferred Expense USD 81.11M 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 92.39M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 2.35M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 1.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DefinedContributionPlanEmployerMatchingContributionPercentOfMatch Defined Contribution Plan, Employer Matching Contribution, Percent of Match pure 1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 1 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap Depreciation Depreciation USD 3.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.162 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0.5 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.032 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.004 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.059 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 18.00M 2024-03-31 2024 Q1 10-Q 2024-05-14 0000950170-24-059504
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 1.29M 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD -1.29M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-276150
us-gaap FairValueOptionChangesInFairValueGainLoss1 Fair Value, Option, Changes in Fair Value, Gain (Loss) USD -1.30M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap FinancingReceivableAccruedInterestWriteoff Financing Receivable, Accrued Interest, Writeoff USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 19.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -87.93M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -71.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -2.24M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncomeTaxExaminationInterestAccrued Income Tax Examination, Interest Accrued USD 300,000 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 10,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -18.46M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 196,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 309,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 1.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -716,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -305,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncreaseDecreaseInAccruedIncomeTaxesPayable Increase (Decrease) in Income Taxes Payable USD -3.27M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 9.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD -1.27M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -2.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -4.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 64,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 4.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap InterestReceivable Interest Receivable USD 600,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 3.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap LeaseCost Lease, Cost USD 13.37M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 53.48M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 1.25M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 10.21M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 11.03M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 10.67M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 10.33M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 9.99M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 12.83M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap Liabilities Liabilities USD 64.20M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 157.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap LiabilitiesCurrent Liabilities, Current USD 32.34M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 7.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap LongTermInvestments Long-term Investments USD 2.15M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 40,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 53.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -59.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -71.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -71.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 3.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingExpenses Operating Expenses USD 78.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -75.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingLeaseCost Operating Lease, Cost USD 10.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 4.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 634,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 40.66M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 6.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 29.84M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingLeasePayments Operating Lease, Payments USD 10.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 30.37M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.113 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 240,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 988,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD -419,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD -37,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 87,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-14 0000950170-24-059504
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 3.28M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 34,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 324,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 54.31M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 129,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 9.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ProceedsFromIncomeTaxRefundFederal ProceedsFromIncomeTaxRefundFederal USD 2.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 84.01M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 202,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 109,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-276150
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 107.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ProceedsFromSecuredLinesOfCredit Proceeds from Secured Lines of Credit USD 2.00M 2022-11-01 2022-11-30 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -87.87M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 28.25M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 8.62M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 305,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 59.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap RestrictedCash Restricted Cash USD 4.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 4.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -382.54M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 12.40M 2026-04-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 221,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding USD 100,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 12,319 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 91.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 2.27M 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share USD/shares 6.73 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 6,507 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 72.25 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 42,301 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 42.86 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.85 2023-07-31 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.855 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.836 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.05 2023-07-31 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.044 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 63,940 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 1.17 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.12 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 111.02M 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.49M 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 2.63 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap SharesIssued Shares, Issued shares 500.00M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 93.19M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.747 2024-01-26 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap StockIssued1 Stock Issued USD 492,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0000950170-24-096665
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 350.76M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 74,000 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 80.73M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 352.04M 2023-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-12-31 2024 FY 10-K 2025-03-17 0000950170-25-040217
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 7.95M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 846,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 200,000 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 1.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 65,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 7.30M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 25.80M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap VariableLeaseCost Variable Lease, Cost USD 3.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093976
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 37.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 37.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455441

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →